Abstract
Purpose
To evaluate the association between the polymorphic variants of chromosomes and menstrual disorders.
Methods
The data from our previous retrospective, single-center cohort study were re-analyzed. Women with regular menstruation were included as controls. Women with menstrual cycle abnormalities were subgrouped according to reproductive causes. The frequency of chromosomal polymorphisms was compared between groups. Regression analysis was used to adjust for potential confounding variables.
Result
A total of 24,578 women composed of 8062 women with regular cycles as the control group and 16,516 women as the menstrual cycle irregularity group were included. When compared with the control group, the incidence of chromosomal polymorphisms in the total menstrual cycle irregularity group, Polycystic ovary syndrome group, and Primary ovarian insufficiency group were significantly higher (4.49% versus 5.34%, P = 0.004, 4.49% versus 5.35%, P = 0.018 and 4.49% versus 5.94%, P = 0.002, respectively). The incidences of inv(9) in the Primary ovarian insufficiency group were significantly higher than that in the control individuals (1.0% versus 1.6%, P = 0.024). Logistic regression analysis showed an effect of chromosomal polymorphisms on menstrual cycle irregularity (OR: 1.62, 95% CI: 1.234–2.187, P = 0.007; adjusted OR: 1.46, 95% CI: 1.153–1.819, P < 0.001). The result demonstrated an effect of chromosomal polymorphisms on the Primary ovarian insufficiency group (OR: 2.52, 95% CI: 1.307–5.177, P < 0.001; adjusted OR: 2.61, 95% CI: 1.371–4.605, P < 0.001).
Conclusion
The study suggests chromosomal polymorphisms adversely affect female menstrual cycle irregularity.
Similar content being viewed by others
Availability of data and materials
All data are available in this paper.
Code availability
Not applicable.
References
Harris H, Titus L, Cramer D, Terry KJI (2017) Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer 140:285–291. https://doi.org/10.1002/ijc.30441
Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy B (1968) The length and variability of the human menstrual cycle. JAMA 203:377–380
Treloar AE (1967) Variation of the human menstrual cycle through reproductive life. Int J Fertil 12:77–126
Negi P, Mishra A, Lakhera P (2018) Menstrual abnormalities and their association with lifestyle pattern in adolescent girls of Garhwal, India. J Family Med Prim Care. 7:804. https://doi.org/10.4103/jfmpc.jfmpc_159_17
Laksham KB, Selvaraj R, Kar SS (2019) Menstrual disorders and quality of life of women in an urban area of Puducherry: a community-based cross-sectional study. J Family Med Prim Care. 8:137. https://doi.org/10.4103/jfmpc.jfmpc_209_18
Lee LK, Chen P, Kaur LK (2006) Menstruation among adolescent girls in Malaysia: a cross-sectional school survey. Singapore Med J 47:869
Deligeoroglou E, Tsimaris P, Deliveliotou A, Christopoulos P (2006) Menstrual disorders during adolescence. Pediatr Endocrinol Rev 3:150–159
Cheng R, Ma Y, Nie Y, Qiao X, Yang Z, Zeng R, Xu L (2017) Chromosomal polymorphisms are associated with female infertility and adverse reproductive outcomes after infertility treatment: a 7-year retrospective study. Reprod Biomed 35:72–80. https://doi.org/10.1016/j.rbmo.2017.03.022
Su Y, Kong G, Su Y, Zhou Y, Lv L, Wang Q, Huang B, Zheng R, Li Q, Yuan H (2015) Correlation analysis of the PNPLA7 gene polymorphism and susceptibility to menstrual disorder. Genet Mol Res 14:1733–1740. https://doi.org/10.4238/2015.March.6.20
Gorai I, Tanaka K, Inada M, Morinaga H, Uchiyama Y, Kikuchi R, Chaki O, Hirahara F (2003) Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-α gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab 88:799–803. https://doi.org/10.1210/jc.2002-020353
He C, Murabito JM (2014) Genome-wide association studies of age at menarche and age at natural menopause. Mol Cell Endocrinol 382:767–779. https://doi.org/10.1016/j.mce.2012.05.003
Lussiana C, Guani B, Mari C, Restagno G, Massobrio M, Revelli O (2008) Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 63:785–795. https://doi.org/10.1097/OGX.0b013e31818957eb
Biggs WS, Demuth RHJ (2011) Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Phys 84:918–924
Chen Z-J, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16 3, 2p21 and 9q33. Nat Genet 3(43):55–59. https://doi.org/10.1038/ng.732
Shi J, Zhang B, Choi J-Y, Gao Y-T, Li H, Lu W, Long J, Kang D, **ang Y-B, Wen W (2016) Age at menarche and age at natural menopause in East Asian women: a genome-wide association study. Age (Dordr) 38:513–523. https://doi.org/10.1007/s11357-016-9939-5
Munro MG, Critchley HO, Fraser IS, Committee FMD, Haththotuwa R, Kriplani A, Bahamondes L, Füchtner C, Tonye R, Archer D (2018) The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet 143:393–408. https://doi.org/10.1002/ijgo.12666
ESHRE TR, Fertility A-SPCWGJ sterility (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25. https://doi.org/10.1016/j.fertnstert.2003.10.004
Reproduction REASPCWG (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks reated to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47. https://doi.org/10.1093/humrep/deh098
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:273–288. https://doi.org/10.1210/jc.2010-1692
POI EGGo, Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, Cifkova R, de Muinck K-SS, Hogervorst E (2016) ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 31:926–937. https://doi.org/10.1093/humrep/dew027
Critchley HO, Maybin JA, Armstrong GM, Williams AR (2020) Physiology of the endometrium and regulation of menstruation. Physiol Rev 100:1149–1179. https://doi.org/10.1152/physrev.00031.2019
Mihm M, Gangooly S, Muttukrishna S (2011) The normal menstrual cycle in women. Anim Reprod Sci 124:229–236. https://doi.org/10.1016/j.anireprosci.2010.08.030
Harlow SD, Campbell OM (2004) Epidemiology of menstrual disorders in develo** countries: a systematic review. BJOG. https://doi.org/10.1111/j.1471-0528.2004.00012.x
Bahamondes L, Ali M (2015) Recent advances in managing and understanding menstrual disorders. F1000 Prime Rep. https://doi.org/10.12703/P7-33
Brinton LA, Moghissi KS, Westhoff CL, Lamb EJ, Scoccia B (2010) Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome). Fertil Steril 94:1787–1792
Lakkawar NJ, Jayavani R, Arthi P, Alaganandam P, Vanajakshi N (2014) A study of menstrual disorders in medical students and its correlation with biological variables. Nat Rev Endocrinol 2:3165–3175. https://doi.org/10.36347/sjams.2014.v02i06.065
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219–231. https://doi.org/10.1038/nrendo.2010.217
Chen Y, Fang S-y (2018) Potential genetic polymorphisms predicting polycystic ovary syndrome. Endocrine Connect 7:R187–R195. https://doi.org/10.1530/EC-18-0121
Khan MJ, Ullah A, Basit S (2019) Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet 12:249. https://doi.org/10.2147/TACG.S200341
Chaudhary H, Patel J, Jain NK, Joshi R (2021) The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 14:1–21. https://doi.org/10.1186/s13048-021-00879-w
Jones MR, Goodarzi M (2016) Genetic determinants of polycystic ovary syndrome: progress and future directions. Fertil Steril 106:25–32. https://doi.org/10.1016/j.fertnstert.2016.04.040
Brand JS, Van Der Schouw YT, Onland-Moret NC, Sharp SJ, Ong KK, Khaw K-T, Ardanaz E, Amiano P, Boeing H, Chirlaque M-D (2013) Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-interact study. Diabetes Care 36:1012–1019. https://doi.org/10.2337/dc12-1020
Jiao X, Ke H, Qin Y, Chen Z-J (2018) Molecular genetics of premature ovarian insufficiency. Trends Endocrinol Metab 29:795–807. https://doi.org/10.1016/j.tem.2018.07.002
Katari S, Aarabi M, Kintigh A, Mann S, Yatsenko SA, Sanfilippo JS, Zeleznik AJ, Rajkovic AJ (2018) Chromosomal instability in women with primary ovarian insufficiency. Hum Reprod 33:531–538. https://doi.org/10.1093/humrep/dey012UNstr
Dvornyk VJ (2012) Genetics of age at menarche: a systematic review. Hum Reprod Update 18:198–210. https://doi.org/10.1093/humupd/dmr050
Ponomarenko I, Reshetnikov E, Altuchova O, Polonikov A, Sorokina I, Yermachenko A, Dvornyk V, Golovchenko O, Churnosov M (2019) Association of genetic polymorphisms with age at menarche in Russian women. Gene 686:228–236. https://doi.org/10.1016/j.gene.2018.11.042
Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, Lunetta KL, Visser JA, Byrne EM, Cousminer DL (2010) Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 42:1077–1085. https://doi.org/10.1038/ng.714
De Sanctis V, Rigon F, Bernasconi S, Bianchin L, Bona G, Bozzola M, Buzi F, De Sanctis C, Tonini G, Radetti G (2019) Age at menarche and menstrual abnormalities in adolescence: does it matter? The evidence from a large survey among Italian secondary schoolgirls. Indian J Pediatr 86:34–41. https://doi.org/10.1007/s12098-018-2822-x
Dambhare DG, Wagh SV, Dudhe JY (2012) Age at menarche and menstrual cycle pattern among school adolescent girls in Central India. Global J Health Sci 4:105. https://doi.org/10.5539/gjhs.v4n1p105
Zegeye DT, Megabiaw B, Mulu A (2009) Age at menarche and the menstrual pattern of secondary school adolescents in northwest Ethiopia. BMC Womens Health 9:1–8. https://doi.org/10.1186/1472-6874-9-29
Vihko R, Apter D (1984) Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 20:231–236. https://doi.org/10.1016/0022-4731(84)90209-7
Dossus L, Kvaskoff M, Bijon A, Fervers B, Boutron-Ruault M-C, Mesrine S, Clavel-Chapelon F (2012) Determinants of age at menarche and time to menstrual cycle regularity in the French E3N cohort. Ann Epidemiol 22:723–730. https://doi.org/10.1016/j.annepidem.2012.07.007
Anai T, Miyazaki F, Tomiyasu T, Matsuo T (2001) Risk of irregular menstrual cycles and low peak bone mass during early adulthood associated with age at menarche. Pediatr Int 43:483–488. https://doi.org/10.1046/j.1442-200X.2001.01442.x
Acknowledgements
We appreciate the contribution of patients, doctors, researchers and teachers to our study. In particular, we would like to thank Wu Hong for counselling and analyzing data.
Funding
The study was supported by National Natural Science Funds (No. 81971354 and No. 81671421), the Korea Research Centre Fund, Sichuan Regional and National Key Research Bases (No. hgzx201803) and Sichuan province natural science foundation, Sichuan Science and Technology Program (No. 2022NSFSC0701).
Author information
Authors and Affiliations
Contributions
XL and CR participated in study design, statistical analysis, interpretation of data and manuscript writing. Material preparation and data collection were performed by LX, ZW, ZX, NY, YZ and QX. The first draft of the manuscript was written by CR and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ran, C., **aoyan, L., Wenjie, Z. et al. Chromosomal polymorphisms and susceptibility to menstrual disorders: a retrospective analysis of 24,578 women. Arch Gynecol Obstet 308, 1577–1585 (2023). https://doi.org/10.1007/s00404-023-07124-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-023-07124-3